Creation Of Centre For Personalised Medicines In UK Should Cut Patient Deaths

A 5 million pound investment in the development of personalised medicines at the University of Liverpool will see the introduction of treatments tailored for individual patients.Liverpool research estimates that a quarter of a million people are admitted to hospital in the UK each year following adverse reactions to a variety of commonly prescribed drugs which costs the NHS an average of £466 million annually. [click link for full article]

More: continued here

Filed under: Genetics on September 12th, 2007